Cytoplasmic Ubiquitin-Specific Protease 19 (USP19) Modulates Aggregation of Polyglutamine-Expanded Ataxin-3 and Huntingtin Through the HSP90 Chaperone

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2016 Jan 26

PMID 26808260

Citations 26

Authors

Wen-Tian He

Xue-Ming Zheng

Yu-Hang Zhang

Yong-Guang Gao

Ai-Xin Song

Francoise Gisou van der Goot

Hong-Yu Hu

Affiliations

Soon will be listed here.

Abstract

Ubiquitin-specific protease 19 (USP19) is one of the deubiquitinating enzymes (DUBs) involved in regulating the ubiquitination status of substrate proteins. There are two major isoforms of USP19 with distinct C-termini; the USP19_a isoform has a transmembrane domain for anchoring to the endoplasmic reticulum, while USP19_b contains an EEVD motif. Here, we report that the cytoplasmic isoform USP19_b up-regulates the protein levels of the polyglutamine (polyQ)-containing proteins, ataxin-3 (Atx3) and huntingtin (Htt), and thus promotes aggregation of their polyQ-expanded species in cell models. Our data demonstrate that USP19_b may orchestrate the stability, aggregation and degradation of the polyQ-expanded proteins through the heat shock protein 90 (HSP90) chaperone system. USP19_b directly interacts with HSP90 through its N-terminal CS (CHORD and SGT1)/P23 domains. In conjunction with HSP90, the cytoplasmic USP19 may play a key role in triage decision for the disease-related polyQ-expanded substrates, suggesting a function of USP19 in quality control of misfolded proteins by regulating their protein levels.

Citing Articles

Enhanced secretion of the amyotrophic lateral sclerosis ALS-associated misfolded TDP-43 mediated by the ER-ubiquitin specific peptidase USP19.

Picard F, Nonaka T, Belotti E, Osseni A, Errazuriz-Cerda E, Jost-Mousseau C Cell Mol Life Sci. 2025; 82(1):76.

PMID: 39948244 PMC: 11825969. DOI: 10.1007/s00018-025-05589-w.

The Role of Protein Quantity Control in Polyglutamine Spinocerebellar Ataxias.

Zhang H, Wang X Cerebellum. 2024; 23(6):2575-2592.

PMID: 39052145 DOI: 10.1007/s12311-024-01722-w.

Ubiquitin-modifying enzymes in Huntington's disease.

Sap K, Geijtenbeek K, Schipper-Krom S, Guler A, Reits E Front Mol Biosci. 2023; 10:1107323.

PMID: 36926679 PMC: 10013475. DOI: 10.3389/fmolb.2023.1107323.

Opposing USP19 splice variants in TGF-β signaling and TGF-β-induced epithelial-mesenchymal transition of breast cancer cells.

Zhang J, van Dinther M, Thorikay M, Mousavi Gourabi B, Kruithof B, Ten Dijke P Cell Mol Life Sci. 2023; 80(2):43.

PMID: 36646950 PMC: 9842591. DOI: 10.1007/s00018-022-04672-w.

Deubiquitinase USP19 extends the residual enzymatic activity of phenylalanine hydroxylase variants.

Sarodaya N, Tyagi A, Kim H, Kang J, Singh V, Hong S Sci Rep. 2022; 12(1):14243.

PMID: 35987969 PMC: 9392723. DOI: 10.1038/s41598-022-18656-0.

References

Waza M, Adachi H, Katsuno M, Minamiyama M, Sang C, Tanaka F . 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration. Nat Med. 2005; 11(10):1088-95. DOI: 10.1038/nm1298. View

McClellan A, Tam S, Kaganovich D, Frydman J . Protein quality control: chaperones culling corrupt conformations. Nat Cell Biol. 2005; 7(8):736-41. DOI: 10.1038/ncb0805-736. View

Balch W, Morimoto R, Dillin A, Kelly J . Adapting proteostasis for disease intervention. Science. 2008; 319(5865):916-9. DOI: 10.1126/science.1141448. View

Gao X, Hu H . Quality control of the proteins associated with neurodegenerative diseases. Acta Biochim Biophys Sin (Shanghai). 2008; 40(7):612-8. DOI: 10.1111/j.1745-7270.2008.00441.x. View

Zhang M, Boter M, Li K, Kadota Y, Panaretou B, Prodromou C . Structural and functional coupling of Hsp90- and Sgt1-centred multi-protein complexes. EMBO J. 2008; 27(20):2789-98. PMC: 2556094. DOI: 10.1038/emboj.2008.190. View

Nagai Y, Popiel H . Conformational changes and aggregation of expanded polyglutamine proteins as therapeutic targets of the polyglutamine diseases: exposed beta-sheet hypothesis. Curr Pharm Des. 2008; 14(30):3267-79. DOI: 10.2174/138161208786404164. View

Lu Y, Adegoke O, Nepveu A, Nakayama K, Bedard N, Cheng D . USP19 deubiquitinating enzyme supports cell proliferation by stabilizing KPC1, a ubiquitin ligase for p27Kip1. Mol Cell Biol. 2008; 29(2):547-58. PMC: 2612522. DOI: 10.1128/MCB.00329-08. View

Williams A, Knutson T, Colomer Gould V, Paulson H . In vivo suppression of polyglutamine neurotoxicity by C-terminus of Hsp70-interacting protein (CHIP) supports an aggregation model of pathogenesis. Neurobiol Dis. 2008; 33(3):342-53. PMC: 2662361. DOI: 10.1016/j.nbd.2008.10.016. View

Powers E, Morimoto R, Dillin A, Kelly J, Balch W . Biological and chemical approaches to diseases of proteostasis deficiency. Annu Rev Biochem. 2009; 78:959-91. DOI: 10.1146/annurev.biochem.052308.114844. View

10.

Reyes-Turcu F, Ventii K, Wilkinson K . Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annu Rev Biochem. 2009; 78:363-97. PMC: 2734102. DOI: 10.1146/annurev.biochem.78.082307.091526. View

11.

Hassink G, Zhao B, Sompallae R, Altun M, Gastaldello S, Zinin N . The ER-resident ubiquitin-specific protease 19 participates in the UPR and rescues ERAD substrates. EMBO Rep. 2009; 10(7):755-61. PMC: 2727442. DOI: 10.1038/embor.2009.69. View

12.

Komander D, Clague M, Urbe S . Breaking the chains: structure and function of the deubiquitinases. Nat Rev Mol Cell Biol. 2009; 10(8):550-63. DOI: 10.1038/nrm2731. View

13.

Bauer P, Nukina N . The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies. J Neurochem. 2009; 110(6):1737-65. DOI: 10.1111/j.1471-4159.2009.06302.x. View

14.

Kubota H . Quality control against misfolded proteins in the cytosol: a network for cell survival. J Biochem. 2009; 146(5):609-16. DOI: 10.1093/jb/mvp139. View

15.

Taipale M, Jarosz D, Lindquist S . HSP90 at the hub of protein homeostasis: emerging mechanistic insights. Nat Rev Mol Cell Biol. 2010; 11(7):515-28. DOI: 10.1038/nrm2918. View

16.

Song A, Zhou C, Peng Y, Gao X, Zhou Z, Fu Q . Structural transformation of the tandem ubiquitin-interacting motifs in ataxin-3 and their cooperative interactions with ubiquitin chains. PLoS One. 2010; 5(10):e13202. PMC: 2951365. DOI: 10.1371/journal.pone.0013202. View

17.

Gao X, Zhou C, Zhou Z, Zhang Y, Zheng X, Song A . Co-chaperone HSJ1a dually regulates the proteasomal degradation of ataxin-3. PLoS One. 2011; 6(5):e19763. PMC: 3098244. DOI: 10.1371/journal.pone.0019763. View

18.

Che M, Jiang Y, Xie Y, Jiang L, Hu H . Aggregation of the 35-kDa fragment of TDP-43 causes formation of cytoplasmic inclusions and alteration of RNA processing. FASEB J. 2011; 25(7):2344-53. DOI: 10.1096/fj.10-174482. View

19.

Jiang Y, Che M, Yuan J, Xie Y, Yan X, Hu H . Interaction with polyglutamine-expanded huntingtin alters cellular distribution and RNA processing of huntingtin yeast two-hybrid protein A (HYPA). J Biol Chem. 2011; 286(28):25236-45. PMC: 3137094. DOI: 10.1074/jbc.M110.216333. View

20.

Hartl F, Bracher A, Hayer-Hartl M . Molecular chaperones in protein folding and proteostasis. Nature. 2011; 475(7356):324-32. DOI: 10.1038/nature10317. View